Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Daclizumab for relapsing remitting multiple sclerosis.
Activation of CD4(+) Foxp3(+) regulatory T cells proceeds normally in the absence of B cells during EAE.
Kinetics of Proinflammatory Monocytes in a Model of Multiple Sclerosis and Its Perturbation by Laquinimod.
Hemianopia and visual loss due to progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis.
Protection of tregs, suppression of Th1 and th17 cells, and amelioration of experimental allergic encephalomyelitis by a physically-modified saline.
Helicobacter pylori Infection in Neuromyelitis Optica and Multiple Sclerosis.
[Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis.]
A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.
CD5-positive B cell subsets in secondary progressive multiple sclerosis.
Monitoring medication adherence in multiple sclerosis using a novel web-based tool: A pilot study.
Association of Missense Mutations of Mediterranean Fever (MEFV) Gene with Multiple Sclerosis in Turkish Population.
The spectrum of post-vaccination inflammatory CNS demyelinating syndromes.
A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann's syndrome.
ZOCOR (simvastatin) Tablets
Growth arrest specific gene 6 protein concentration in cerebrospinal fluid correlates with relapse severity in multiple sclerosis.
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis.
MRI of the cervical nerve roots in the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy: a single-institution, retrospective case-control study.
Systematic review of occupational therapy-related interventions for people with multiple sclerosis: part 2. Impairment.
A case of acute disseminated encephalomyelitis associated with hepatitis C virus infection.
A case of multiple sclerosis with pure, massive superficial demyelination.
Reibergram and oligoclonal bands in diagnosis of multiple sclerosis.
Energy conservation for fatigue management in multiple sclerosis: a pilot randomized controlled trial.
Neuroplasticity and functional recovery in multiple sclerosis.
Self-efficacy and health status improve after a wellness program in persons with multiple sclerosis.
Protein tyrosine phosphatase receptor type z negatively regulates oligodendrocyte differentiation and myelination.
Pages
« first
‹ previous
…
268
269
270
271
272
273
274
275
276
…
next ›
last »